Caryn McDowell was Appointed as Senior Vice President, General Counsel, and Corporate Secretary at Revance

Date of management change: May 01, 2018 

What Happened?

Newark, -based Revance Appointed Caryn McDowell as Senior Vice President, General Counsel, and Corporate Secretary

 

About the Company

Revance Therapeutics is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, including muscle movement disorders and pain. The company`s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines, cervical dystonia and plantar fasciitis with the potential to be the first long-acting neuromodulator. Revance has developed a proprietary, stabilizing excipient peptide technology designed to create novel, differentiated therapies. The company has a comprehensive pipeline based upon its peptide technology, including injectable and topical formulations of daxibotulinumtoxinA.

 

About the Person

Caryn McDowell  is Senior Vice President, General Counsel, and Corporate Secretary at Revance. Previously, Caryn held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Roberts Michael, Trifiro Noelle, Lagaly Tom, Dukes Marie, Goldhand Joanne, Johnson Daniel, Moioli Giacomina, Rascher Timothy, Silverman Adam, Corbett Dorothy, Strother James

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.